Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Avanos Medical (AVNS) Gross Profit (2016 - 2025)

Avanos Medical's Gross Profit history spans 11 years, with the latest figure at $92.9 million for Q3 2024.

  • For Q3 2024, Gross Profit fell 2.72% year-over-year to $92.9 million; the TTM value through Sep 2024 reached $378.3 million, down 2.4%, while the annual FY2023 figure was $379.7 million, 3.68% down from the prior year.
  • Gross Profit for Q3 2024 was $92.9 million at Avanos Medical, down from $95.6 million in the prior quarter.
  • Across five years, Gross Profit topped out at $110.1 million in Q3 2022 and bottomed at $32.0 million in Q4 2021.
  • The 5-year median for Gross Profit is $95.0 million (2023), against an average of $92.3 million.
  • The largest annual shift saw Gross Profit crashed 63.01% in 2021 before it soared 221.56% in 2022.
  • A 5-year view of Gross Profit shows it stood at $86.5 million in 2020, then plummeted by 63.01% to $32.0 million in 2021, then skyrocketed by 221.56% to $102.9 million in 2022, then decreased by 7.68% to $95.0 million in 2023, then decreased by 2.21% to $92.9 million in 2024.
  • Per Business Quant, the three most recent readings for AVNS's Gross Profit are $92.9 million (Q3 2024), $95.6 million (Q2 2024), and $94.8 million (Q1 2024).